Led by Dr Joseph Choukroun, the inventor of the process for PRF technique and the protocol i-PRF is a real scientific and clinical innovation that enables practitioners to improve their results in bone grafts.

Research into i-PRF (“i” as injectable) has been directed towards obtaining a blood concentrate with very high leukocyte content but which coagulates a few minutes after the end of spin. This “super PRF” is produced with new tubes i-PRF specific for this preparation.

The use of i-PRF is in its infancy, but already, the results in both oral surgery in regenerative medicine are very promising injection into soft tissue to increase vascularity and perhaps improve the biotype, injection into the bone graft particles (biomaterials) to coagulate and get a “solid” free of all movements granules.

Advanced Platelet Rich Fibrin (APRF) is a new advanced technology that helps heal wounds anywhere in the body, including those involved in oral surgery, using the patient’s own blood.

The concept of PRF (Platelet Rich Fibrin) is based on the centrifugation of whole blood without anticoagulants. (J. Choukroun et al. 2001). At the end of the spin, a fibrin clot containing the majority of the platelets and white blood cells is obtained.

This fibrin clot called Platelet Rich Fibrin or PRF will release gradually and growth factors or cytokines in the site (VEGF, PDGF, TGF Beta, Thrombospondin)

The expected objective of these growth factors is to accelerate the soft tissue and bone healing.